Financials Cronos Group Inc.

Equities

CRON

CA22717L1013

Pharmaceuticals

Market Closed - Toronto S.E. 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
3.53 CAD +2.62% Intraday chart for Cronos Group Inc. +8.95% +27.44%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,477 3,145 1,859 1,304 1,056 1,348 - -
Enterprise Value (EV) 1 1,348 3,145 583.8 109.9 -113.6 161.5 157.5 1,348
P/E ratio 2.12 x -33.6 x -3.67 x -5.62 x -10.7 x -57.5 x -51.4 x -10,697 x
Yield - - - - - - - -
Capitalization / Revenue 104 x 53.8 x 19.7 x 10.4 x 8.92 x 9.83 x 8.23 x 7.25 x
EV / Revenue 40.1 x 53.8 x 6.18 x 0.88 x -0.96 x 1.18 x 0.96 x 7.25 x
EV / EBITDA -8.64 x -17.1 x -2.87 x -1 x 1.31 x -3.2 x -4.14 x -71.8 x
EV / FCF -5.65 x -14.2 x -2.79 x -0.87 x 1.85 x -9.19 x -8.8 x -67.7 x
FCF Yield -17.7% -7.02% -35.8% -114% 54.2% -10.9% -11.4% -1.48%
Price to Book 1.41 x - - - - - - -
Nbr of stocks (in thousands) 348,782 355,773 373,287 379,095 381,114 382,011 - -
Reference price 2 9.970 8.840 4.980 3.440 2.770 3.530 3.530 3.530
Announcement Date 3/30/20 2/26/21 3/1/22 2/28/23 2/29/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 33.58 58.47 94.48 125 118.4 137.1 163.9 185.9
EBITDA 1 -156 -184.3 -203.7 -109.7 -86.52 -50.43 -38.03 -18.77
EBIT 1 -161.5 -224.4 -711.5 -169.9 -115.1 -82.11 -62.63 -34.61
Operating Margin -480.91% -383.88% -753.13% -135.84% -97.2% -59.88% -38.2% -18.61%
Earnings before Tax (EBT) 1 1,648 -91.7 -504.1 -183.1 -99.99 -21.6 -9.154 4.648
Net income 1 1,649 -91.53 -502.8 -229.6 -100.4 -17.26 -10.73 2.356
Net margin 4,911.6% -156.55% -532.15% -183.6% -84.78% -12.59% -6.54% 1.27%
EPS 2 4.708 -0.2628 -1.358 -0.6123 -0.2579 -0.0614 -0.0687 -0.000330
Free Cash Flow 1 -238.5 -220.8 -209.1 -125.7 -61.54 -17.57 -17.9 -19.93
FCF margin -710.19% -377.68% -221.35% -100.54% -51.97% -12.82% -10.92% -10.72%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 3/30/20 2/26/21 3/1/22 2/28/23 2/29/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 25.91 32.74 32.51 29.62 28.28 31.14 26.91 25.45 34.23 32.46 32.07 33.48 35.17 36.88 36.11
EBITDA 1 -59.38 -34.72 -24.55 -24.14 -29.32 -28.86 -22.39 -21.28 -20.95 -19.98 -14.2 -13.57 -12.24 -10.81 -13.29
EBIT 1 -71.62 -206.4 -46.82 -36.04 -41.9 -40.43 -29.38 -27.59 -30.04 -29.36 -23.2 -21.48 -19.39 -17.24 -
Operating Margin -276.44% -630.49% -144.01% -121.7% -148.18% -129.85% -109.19% -108.41% -87.77% -90.47% -72.35% -64.17% -55.12% -46.75% -
Earnings before Tax (EBT) 1 98.29 -170.3 -41.94 -26.51 -46.99 -63.75 -27.64 -7.817 -3.924 -61.77 -7.12 -4.746 -1.762 -0.404 -
Net income 1 98.91 -169.6 -42.39 -25.97 -49.99 -107.3 -25.6 -11.19 -2.268 -60.79 -4.809 -3.028 -0.9226 0.6014 -
Net margin 381.81% -518.07% -130.38% -87.68% -176.8% -344.67% -95.16% -43.95% -6.63% -187.29% -14.99% -9.04% -2.62% 1.63% -
EPS 2 0.2666 -0.4569 -0.1169 -0.0642 -0.1352 -0.2857 -0.0668 -0.0268 - -0.1629 -0.0139 -0.0139 -0.006870 - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/18/22 3/1/22 5/10/22 8/9/22 11/7/22 2/28/23 5/9/23 8/8/23 11/8/23 2/29/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 2,129 - 1,275 1,194 1,169 1,187 1,191 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -238 -221 -209 -126 -61.5 -17.6 -17.9 -19.9
ROE (net income / shareholders' equity) 66.7% -4.23% -26% -13.6% -2.29% -1.95% -4.7% -3.3%
ROA (Net income/ Total Assets) 103% -3.64% -23.8% -12.9% -2.17% -2.7% -4.5% -3.1%
Assets 1 1,608 2,513 2,109 1,776 4,621 639.4 238.3 -75.99
Book Value Per Share 7.090 - - - - - - -
Cash Flow per Share 2 -0.5400 -0.5100 -0.5300 -0.3200 -0.1500 -0.0100 0.0500 -0.0400
Capex 1 55.1 39.9 14.1 4.7 3.4 5.17 4.69 5.53
Capex / Sales 164.01% 68.23% 14.97% 3.76% 2.87% 3.77% 2.86% 2.97%
Announcement Date 3/30/20 2/26/21 3/1/22 2/28/23 2/29/24 - - -
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
3.53 CAD
Average target price
3.567 CAD
Spread / Average Target
+1.05%
Consensus
  1. Stock Market
  2. Equities
  3. CRON Stock
  4. Financials Cronos Group Inc.